Feasibility of Spinal Manual Therapy Interventions for a Future Clinical Study of Back Pain (NCT05778396) | Clinical Trial Compass
CompletedNot Applicable
Feasibility of Spinal Manual Therapy Interventions for a Future Clinical Study of Back Pain
Switzerland81 participantsStarted 2023-04-04
Plain-language summary
This study aims to compare two different spinal manual therapy interventions of the back to determine if they are viable and acceptable for a future study investigating the treatment of patients with back pain. The two proposed spinal manual therapy interventions are widely used in the fields of chiropractic, physical therapy, osteopathy, and manual medicine to treat back pain and improve function. This is a randomized study, meaning that participants are randomly assigned (like tossing a coin) to one of two manual spinal therapy interventions.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged 18 years or older
* With or without experience of spinal manual therapy
* With or without experience of current low back pain
Exclusion Criteria:
* Serious spinal pathology (e.g. spinal fracture, cancer or infection)
* History of lumbar spine surgery
* Currently under care or in consultation with a specialist, chiropractor, physiotherapist, or osteopath for current back pain
* Manual medicine health care provider (i.e., chiropractor, physiotherapist, osteopath, massage therapist, manual medicine trained physician)
* Have a serious comorbidity preventing them from attending the research clinic and receiving the interventions
* Pregnant or breastfeeding status
* Involved in pending litigation related to back pain
* Already participating in another research study related to back pain
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Participant blinding success, as measured by the validated Bang blinding index, immediately after intervention session 1.
Timeframe: Immediately after intervention session 1 (study day 1)
2
Participant blinding success, as measured by the validated Bang blinding index, immediately after intervention session 2.
Timeframe: Immediately after intervention session 2 (study day 2, between 48 hours and 2 weeks after study day 1)